A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

GBS is a rare disorder where the immune system attacks the peripheral nervous system which carries signals from the brain and spinal cord to the rest of the body, causing muscle weakness and paralysis ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

In a new study, scientists at the Leibniz Institute for Neurobiology (LIN) and University Hospital Magdeburg demonstrated ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Christian Fellowship Center Lead Pastor Brian Dube is making a miraculous recovery from a case of near-fatal paralysis from a ...

Maharashtra has witnessed an increase in the number of Guillain-Barre Syndrome (GBS) cases. GBS is a rare neurological ...

NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...

Guillain Barré Syndrome overview: symptoms, causes, treatment, and potential complications, including recent outbreak in Pune ...